Douglas C. Bryant

Douglas C. Bryant (chief executive) discloses dealings in 3 companies, chiefly Quidel Corp, QuidelOrtho Corp and Luminex Corp. In total, 300 filings cover trades dated from 16 July 2007 to 3 February 2024.

The open-market side counts 20 purchases for €4.8M alongside 77 sales for €43.9M. Taken together, the sales exceed the purchases by €39.0M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 112 share grants and 88 option exercises.

Half of the purchases are above €110k and half below. On 2 out of 5 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster. For 15 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 13% of cases, with a median move of -4.5%. These figures describe past trades and do not predict future prices.

The latest filing, published on 5 February 2024, reports a share grant in QuidelOrtho Corp. The last purchase on record was published on 22 February 2021, which is 2,070 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.